Eris Lifesciences Ltd. (ERIS) Lifesciences Share Price: ERIS trades near 52-week low as stock stays weak
- September 29, 2026
- Posted by: Chaitanya Auti
- Category: News
Eris Lifesciences Share Price is trading at Rs 1,127, up 0.12% today, and remains close to its 52-week low with a market capitalisation of Rs 15,617.8 crore. ERIS Share Price Today is drawing attention because the latest Univest data confirms the price event, while not establishing a company-specific catalyst.
Eris Lifesciences Share Price is trading at Rs 1,127, up 0.12% today, and the stock remains close to its 52-week low. The company’s market capitalisation stands at Rs 15,617.8 crore, placing ERIS among mid-sized names in the Healthcare space. The latest Eris Lifesciences Share Price Today move reflects a narrow intraday range rather than a broad rebound, and the latest Univest data confirms the price event but does not establish a company-specific catalyst. For investors tracking Eris Lifesciences Stock News, the main question is not only why the share price is weak, but also whether the current price action aligns with the technical picture and the company’s valuation profile.
At 9:23 AM IST, Eris Lifesciences Share Price had moved between Rs 1,115.3 and Rs 1,128.1, after opening at Rs 1,119.9 and versus a previous close of Rs 1,125.7. That keeps Eris Lifesciences Share Price Today firmly in focus for traders looking at 52-week low stocks, stocks in news and market movers in the Indian stock market. The next sections examine price action, technicals, fundamentals, ownership structure and sector context to show why Eris Lifesciences Stock News is attracting attention on Univest.
Eris Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,127 |
| Previous Close | Rs 1,125.7 |
| Today's Move | +Rs 1.3 (+0.12%) |
| Open | Rs 1,119.9 |
| High | Rs 1,128.1 |
| Low | Rs 1,115.3 |
| Market Capitalisation | Rs 15,617.8 crore |
Eris Lifesciences Ltd. (ERIS) traded at Rs 1,127 versus the previous close of Rs 1,125.7, a rise of 0.12%. The stock opened at Rs 1,119.9, reached a high of Rs 1,128.1, touched a low of Rs 1,115.3.
Eris Lifesciences Share Price Today shows a restrained start to the session, with ERIS last traded at Rs 1,127, a gain of Rs 1.3 from the previous close of Rs 1,125.7. The stock opened at Rs 1,119.9, touched a high of Rs 1,128.1 and a low of Rs 1,115.3. This narrow band suggests that Eris Lifesciences Share Price is being shaped by cautious price action rather than a sharp directional move.
The stock is trading close to its 52-week low, which makes the current level important for anyone following Eris Lifesciences Share Price Live updates and Eris Lifesciences Stock Performance. In broad market terms, ERIS sits in the list of stocks at 52 week low and oversold stocks that can attract attention from technical watchers. Even so, the latest Eris Lifesciences Share Price movement should be read as a price-based event first, not as proof of a fresh business trigger. From here, the key question is whether the chart structure can stabilise above nearby support levels.
Eris Lifesciences Ltd. (ERIS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,617.8 crore |
| P/E Ratio | 24.25x |
| P/B Ratio | 3.87x |
| ROE | 19.23% |
| ROCE | 14.47% |
| EPS | Rs 46.41 |
| Book Value Per Share | Rs 290.65 |
| Dividend Yield | 0% |
Eris Lifesciences Ltd. (ERIS) fundamental metrics show P/E 24.25x, P/B 3.87x, ROE 19.23%, ROCE 14.47%. These figures provide context only and are not a buy or sell signal.
Eris Lifesciences Ltd. has a market capitalisation of Rs 15,617.8 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.25x, P/B at 3.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.23% and ROCE of 14.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 46.41, book value per share of Rs 290.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.98x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 24.25x |
| Benchmark Median P/E | 26.98x |
| Benchmark Average P/E | 39.36x |
| Benchmark P/E Range | 0x to 616.89x |
| Company P/B Ratio | 3.87x |
| Benchmark Median P/B | 2.74x |
| Company ROE | 19.23% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 14.47% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 15,617.8 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Eris Lifesciences Ltd. (ERIS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 24.25x, which is below the benchmark median of 26.98x, a difference of -10.12%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Eris Lifesciences Ltd. (ERIS) has a ROE of 19.23%, which is above the benchmark median of 11.23%, a difference of +71.24%. Eris Lifesciences Ltd. (ERIS) has a ROCE of 14.47%, which is above the benchmark median of 13.17%, a difference of +9.87%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glenmark Life Sciences Ltd. | ALIVUS | 15,627.58 | 25.92 | 4.48 | 18.41 | 24.61 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 15,532.42 | 22.4 | 2.66 | 12.35 | 11.74 |
| Natco Pharma Ltd. | NATCOPHARM | 15,708.15 | 13.73 | 1.68 | 16.3 | 17.16 |
| ONESOURCE SPECL PHARMA L | ONESOURCE | 15,818.68 | 0 | 2.7 | -1.26 | 0.44 |
| Astrazeneca Pharma India Ltd. | ASTRAZEN | 15,108.25 | 89.07 | 16.71 | 23.02 | 31.24 |
Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 24.25x compared with the displayed peer median of 22.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.23% compares with a peer median of 16.3% across the companies shown in the table. ROCE stood at 14.47% versus the displayed peer median of 17.16%, providing a capital-efficiency comparison. Eris Lifesciences Ltd. (ERIS) has a market capitalisation of Rs 15,617.8 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Eris Lifesciences
- Eris Lifesciences Share Price is trading near its 52-week low, which keeps the stock on radar screens.
- Eris Lifesciences Share Price Today remains below the 50 DMA and 200 DMA, which signals weak momentum.
- Eris Lifesciences Fundamental Analysis shows ROE of 19.23% and ROCE of 14.47%, both useful quality markers.
- The company’s P/E of 24.25 is below the industry median of 26.98 in Pharmaceuticals & Drugs.
- Eris Lifesciences Stock News stays relevant because price, valuation and sector benchmarking are all in play.
About Eris Lifesciences
Eris Lifesciences operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the Indian listed pharma universe and is tracked by investors for its earnings profile, valuation metrics and position within a broad peer group. The latest data points available for Eris Lifesciences Share Price include market cap, earnings, book value, profitability ratios and recent quarterly revenue, which together help frame the stock beyond day-to-day price movement.
The business context matters because Eris Lifesciences Share Price Today is not moving in isolation. Pharmaceutical stocks are often assessed through a mix of financial quality, pricing power, capital efficiency and sector comparison. For that reason, Eris Lifesciences Stock News tends to attract both technical watchers and fundamental investors. When a stock sits near a 52-week low, the business profile becomes especially important for understanding whether the price action is merely market-driven or whether the valuation conversation is changing.
Track Eris Lifesciences Share Price on Univest
Use Eris Lifesciences Ltd. (ERIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
You can track Eris Lifesciences Share Price on Univest for live price updates, Eris Lifesciences Technical Analysis, Eris Lifesciences Fundamental Analysis, shareholding pattern, 52-week levels and sector context. Univest also helps users review Eris Lifesciences Share Price Today alongside peer comparison, market capitalisation and key ratios in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Eris Lifesciences Share Price near a 52-week low?
Ans. Eris Lifesciences Share Price is near a 52-week low because the stock is trading below its 50 DMA and 200 DMA, while RSI at 22.97 shows weak momentum. The latest data confirms price pressure.
What is Eris Lifesciences Share Price today?
Ans. Eris Lifesciences Share Price is Rs 1,127, up 0.12% from the previous close of Rs 1,125.7. The stock opened at Rs 1,119.9 and moved within a tight intraday range. The stock moved 0.12% during the session.
How does Eris Lifesciences compare with Healthcare peers?
Ans. Eris Lifesciences Share Price sits in a peer group with similar market capitalisation, while its P/E is below the industry median. Its ROE is stronger than the benchmark median as well.
What is the market capitalisation of Eris Lifesciences?
Ans. Eris Lifesciences has a market capitalisation of Rs 15,617.8 crore. That places the company in the mid-cap range within the Pharmaceuticals & Drugs industry. The company operates in the Healthcare sector.
What should investors monitor next in Eris Lifesciences Share Price?
Ans. Investors should monitor whether Eris Lifesciences Share Price can recover above the 50 DMA, how RSI behaves from weak levels, and whether the stock can stabilise near its support zone.
Why is Eris Lifesciences Stock News drawing attention?
Ans. Eris Lifesciences Stock News is drawing attention because the share price is near a yearly low, momentum is weak, and valuation and profitability need to be viewed together for context.